Document Detail


Rational approach to treatment options for Lennox-Gastaut syndrome.
MedLine Citation:
PMID:  21790561     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Lennox-Gastaut syndrome (LGS) is an intractable childhood-onset epileptic encephalopathy. Seizure freedom is rare in LGS. One of the hallmarks of LGS is medical intractability, with generally poor response to antiepileptic drugs (AEDs). Nevertheless, several treatment options are available that can mitigate the severity of seizures and curtail their frequency. New AEDs have been validated in randomized, controlled trials for the treatment of seizures in LGS. In some cases, nonpharmacologic options may be effective, although more data are needed to confirm efficacy outcomes. Comprehensive patient assessments are critical to achieve an optimal AED treatment regimen and minimize the potential for adverse effects.
Authors:
Georgia D Montouris
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Epilepsia     Volume:  52 Suppl 5     ISSN:  1528-1167     ISO Abbreviation:  Epilepsia     Publication Date:  2011 Aug 
Date Detail:
Created Date:  2011-07-27     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  2983306R     Medline TA:  Epilepsia     Country:  United States    
Other Details:
Languages:  eng     Pagination:  10-20     Citation Subset:  IM    
Copyright Information:
Wiley Periodicals, Inc. © 2011 International League Against Epilepsy.
Affiliation:
Department of Neurology, Boston University School of Medicine, Boston Medical Center, Boston, Massachusetts, U.S.A.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Definition and natural history of Lennox-Gastaut syndrome.
Next Document:  Strategies for transitioning to adult care for youth with Lennox-Gastaut syndrome and related disord...